These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26850499)

  • 1. Torsades de pointes after adenosine administration.
    Teodorovich N; Margolin E; Kogan Y; Paz O; Swissa M
    J Electrocardiol; 2016; 49(2):171-3. PubMed ID: 26850499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine induced torsades de pointes in a child with congenital long QT syndrome.
    Celiker A; Tokel K; Cil E; Ozkutlu S; Ozme S
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 1):1814-7. PubMed ID: 7838793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary adenosine-induced torsades de pointes during fractional flow reserve measurement.
    Degrauwe S; Azzano A; Iglesias JF; Zivelonghi C; Verheye S; Convens C; Vermeersch P; Scott B
    Cardiol J; 2019; 26(5):612-613. PubMed ID: 31701514
    [No Abstract]   [Full Text] [Related]  

  • 4. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine-induced torsades de pointes.
    Harrington GR; Froelich EG
    Chest; 1993 Apr; 103(4):1299-301. PubMed ID: 8131497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal repolarization dynamics in a patient with KCNE1(G38S) who presented with torsades de pointes.
    Yamaguchi Y; Mizumaki K; Hata Y; Inoue H
    J Electrocardiol; 2016; 49(1):94-8. PubMed ID: 26520166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
    Kirchhof P; Franz MR; Bardai A; Wilde AM
    J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin induced Torsades de Pointes: case report and review of the literature.
    Rezkalla MA; Pochop C
    S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsades de Pointes after Ondansetron Infusion in 2 Patients.
    Lee DY; Trinh T; Roy SK
    Tex Heart Inst J; 2017 Oct; 44(5):366-369. PubMed ID: 29259513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-loop, clockwise QT-RR hysteresis immediately before the onset of torsades de pointes in type 2 long QT syndrome.
    Nakaji G; Fujiwara M; Fukata M; Yasuda S; Odashiro K; Maruyama T; Akashi K
    J Electrocardiol; 2010; 43(3):261-3. PubMed ID: 20079908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conversion to sinus rhythm].
    Brunckhorst CB
    Praxis (Bern 1994); 2006 Feb; 95(7):247-8. PubMed ID: 16524116
    [No Abstract]   [Full Text] [Related]  

  • 13. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine.
    Mittal SR
    J Assoc Physicians India; 2014 May; 62(5):426-7. PubMed ID: 25438492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsades de pointes complicating pentamidine therapy of Pneumocystis carinii pneumonia in acute myelogenous leukemia.
    Otsuka M; Kanamori H; Sasaki S; Taguchi J; Harano H; Ogawa K; Matsuzaki M; Mohri H; Okubo T; Sumita S; Ochiai H
    Intern Med; 1997 Oct; 36(10):705-8. PubMed ID: 9372331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of short QT-interval postventricular arrhythmia arrest from Torsade De Pointes, a new phenotype, or the result of tachycardia-mediated imbalance.
    Ifedili I; Maturana M; Kayali S; Levine Y; Kabra R; Jha SK
    J Cardiovasc Electrophysiol; 2024 Mar; 35(3):501-504. PubMed ID: 38174843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
    Makai A; Rudas L; Liszkai G; Fazekas T
    Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probable case of torsades de pointes induced by fluconazole.
    Khazan M; Mathis AS
    Pharmacotherapy; 2002 Dec; 22(12):1632-7. PubMed ID: 12495173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.